Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
Annual Reports
NA
Finished Drug Prices
NA
1. T-gen
2. Tebamide
3. Ticon
4. Tigan
5. Trimethobenzamide
6. Trimethobenzamide Monohydrochloride
1. 554-92-7
2. Trimethobenzamide Hcl
3. Tigan
4. Nauseton
5. Ametik Hydrochloride
6. Ro 2-9578
7. N-(4-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxybenzamide Hydrochloride
8. Tribenzagan Hydrochloride
9. Nsc-37882
10. Wdq5p1sx7q
11. Trimethobenzamide Hydrochloride [usp]
12. Poligerim
13. Tebamide
14. Trimethobenzamide (hydrochloride)
15. N-(p-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxybenzamide Monohydrochloride
16. Benzamide, N-((4-(2-(dimethylamino)ethoxy)phenyl)methyl)-3,4,5-trimethoxy-, Monohydrochloride
17. N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4,5-trimethoxybenzamide;hydrochloride
18. 554-92-7 (hcl)
19. Ibikin
20. Anaus
21. Ticon
22. Dsstox_cid_27754
23. Dsstox_rid_82531
24. Dsstox_gsid_47774
25. T-gen
26. Trimethobenzamide Hydrochloride (usp)
27. N-{[4-(2-dimethylaminoethoxy)phenyl]methyl}-3,4,5-trimethoxy-benzamide Hydrochloride
28. Ncgc00016509-01
29. Trimethobenzamidehydrochloride
30. Cas-554-92-7
31. Einecs 209-075-6
32. Unii-wdq5p1sx7q
33. Nsc 37882
34. N-[4-[2-(dimethylamino)ethoxy]benzyl]-3,4,5-trimethoxybenzamide Hydrochloride
35. Prestwick_526
36. Trimethobenzamidehcl
37. 4-(2-dimethylaminoethoxy)-n-(3,4,5-trimethoxybenzoyl)benzylamine Hydrochloride
38. N-(p-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxybenzamide Hydrochloride
39. Schembl41339
40. Mls002154193
41. Spectrum1500594
42. Chembl1200887
43. Dtxsid7047774
44. Hms1568o21
45. Hms1921g21
46. Pharmakon1600-01500594
47. Nsc37882
48. Tox21_110465
49. Ccg-40276
50. Hy-12751a
51. Mfcd00057999
52. Nsc757359
53. S5483
54. Akos022172835
55. Tox21_110465_1
56. Cs-7696
57. Nsc-757359
58. Benzamide, N-(p-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxy-, Hydrochloride
59. Benzamide, N-(p-(2-(dimethylamino)ethoxy)benzyl)-3,4,5-trimethoxy-, Monohydrochloride
60. Benzamide,n-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4,5-trimethoxy-,monohydrochloride
61. Ncgc00016509-06
62. Ncgc00094803-01
63. Ncgc00094803-02
64. Benzamide,4,5-trimethoxy-, Hydrochloride
65. Bs-17063
66. Smr001233483
67. Trimethobenzamide Hydrochloride [mi]
68. Benzamide,4,5-trimethoxy-, Monohydrochloride
69. Ft-0736653
70. T3525
71. Trimethobenzamide Hydrochloride [vandf]
72. C75602
73. D02733
74. Trimethobenzamide Hydrochloride [mart.]
75. Trimethobenzamide Hydrochloride [usp-rs]
76. Trimethobenzamide Hydrochloride [who-dd]
77. Wln: 1or Bo1 Co1 Evm1r Do2n1&1 &gh
78. 554t927
79. A870178
80. Sr-05000001733-3
81. Trimethobenzamide Hydrochloride [orange Book]
82. Q27292581
83. Trimethobenzamide Hydrochloride [usp Monograph]
84. N-[p-[2-(dimethylamino)ethoxy]benzyl]-3,5-trimethoxybenzamide Hydrochloride
85. 4-[(2-dimethylamino)ethoxy]-n-(3,5-trimethoxybenzoyl)benzylamine Hydrochloride
86. N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4,5-trimethoxybenzamide Monohydrochloride
Molecular Weight | 424.9 g/mol |
---|---|
Molecular Formula | C21H29ClN2O5 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 10 |
Exact Mass | 424.1764997 g/mol |
Monoisotopic Mass | 424.1764997 g/mol |
Topological Polar Surface Area | 69.3 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 440 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Tigan |
Drug Label | Chemically, trimethobenzamide HCl is N-[p-[2-(dimethylamino)ethoxy]benzyl]-3,4,5-trimethoxybenzamide monohydrochloride. It has a molecular weight of 424.93 and the following structural formula: Capsules: Each 300-mg Tigan capsule for oral use conta... |
Active Ingredient | Trimethobenzamide hydrochloride |
Dosage Form | Capsule; Injectable |
Route | Injection; Oral |
Strength | 300mg; 100mg/ml |
Market Status | Prescription |
Company | Par Sterile Products; King Pharms |
2 of 4 | |
---|---|
Drug Name | Trimethobenzamide hydrochloride |
PubMed Health | Trimethobenzamide (By mouth) |
Drug Classes | Antiemetic |
Drug Label | Chemically, trimethobenzamide HCl is N-[p-[2-(dimethylamino)ethoxy]benzyl]-3,4,5-trimethoxybenzamide monohydrochloride. It has a molecular weight of 424.93 and the following structural formula: Capsules: Each 300-mg Tigan capsule for oral use conta... |
Active Ingredient | Trimethobenzamide hydrochloride |
Dosage Form | Capsule; Injectable |
Route | Injection; Oral |
Strength | 300mg; 100mg/ml |
Market Status | Prescription |
Company | Mutual Pharma; Gavis Pharms; Luitpold |
3 of 4 | |
---|---|
Drug Name | Tigan |
Drug Label | Chemically, trimethobenzamide HCl is N-[p-[2-(dimethylamino)ethoxy]benzyl]-3,4,5-trimethoxybenzamide monohydrochloride. It has a molecular weight of 424.93 and the following structural formula: Capsules: Each 300-mg Tigan capsule for oral use conta... |
Active Ingredient | Trimethobenzamide hydrochloride |
Dosage Form | Capsule; Injectable |
Route | Injection; Oral |
Strength | 300mg; 100mg/ml |
Market Status | Prescription |
Company | Par Sterile Products; King Pharms |
4 of 4 | |
---|---|
Drug Name | Trimethobenzamide hydrochloride |
PubMed Health | Trimethobenzamide (By mouth) |
Drug Classes | Antiemetic |
Drug Label | Chemically, trimethobenzamide HCl is N-[p-[2-(dimethylamino)ethoxy]benzyl]-3,4,5-trimethoxybenzamide monohydrochloride. It has a molecular weight of 424.93 and the following structural formula: Capsules: Each 300-mg Tigan capsule for oral use conta... |
Active Ingredient | Trimethobenzamide hydrochloride |
Dosage Form | Capsule; Injectable |
Route | Injection; Oral |
Strength | 300mg; 100mg/ml |
Market Status | Prescription |
Company | Mutual Pharma; Gavis Pharms; Luitpold |
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-08-19
Pay. Date : 2013-07-05
DMF Number : 26950
Submission : 2013-06-11
Status : Active
Type : II
Date of Issue : 2019-10-07
Valid Till : 2022-07-02
Written Confirmation Number : WC-0226
Address of the Firm :
NDC Package Code : 14593-884
Start Marketing Date : 2020-04-17
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4088
Submission : 1981-02-27
Status : Active
Type : II
NDC Package Code : 17205-416
Start Marketing Date : 1981-02-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19965
Submission : 2006-11-10
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7721
Submission : 1988-10-20
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4694
Submission : 1982-10-14
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27428
Submission : 2014-03-13
Status : Inactive
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Trimethobenzamide HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trimethobenzamide HCl, including repackagers and relabelers. The FDA regulates Trimethobenzamide HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trimethobenzamide HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Trimethobenzamide HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Trimethobenzamide HCl supplier is an individual or a company that provides Trimethobenzamide HCl active pharmaceutical ingredient (API) or Trimethobenzamide HCl finished formulations upon request. The Trimethobenzamide HCl suppliers may include Trimethobenzamide HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Trimethobenzamide HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Trimethobenzamide HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Trimethobenzamide HCl active pharmaceutical ingredient (API) in detail. Different forms of Trimethobenzamide HCl DMFs exist exist since differing nations have different regulations, such as Trimethobenzamide HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Trimethobenzamide HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Trimethobenzamide HCl USDMF includes data on Trimethobenzamide HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Trimethobenzamide HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Trimethobenzamide HCl suppliers with USDMF on PharmaCompass.
A Trimethobenzamide HCl written confirmation (Trimethobenzamide HCl WC) is an official document issued by a regulatory agency to a Trimethobenzamide HCl manufacturer, verifying that the manufacturing facility of a Trimethobenzamide HCl active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Trimethobenzamide HCl APIs or Trimethobenzamide HCl finished pharmaceutical products to another nation, regulatory agencies frequently require a Trimethobenzamide HCl WC (written confirmation) as part of the regulatory process.
click here to find a list of Trimethobenzamide HCl suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Trimethobenzamide HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Trimethobenzamide HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Trimethobenzamide HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Trimethobenzamide HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Trimethobenzamide HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Trimethobenzamide HCl suppliers with NDC on PharmaCompass.
Trimethobenzamide HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Trimethobenzamide HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Trimethobenzamide HCl GMP manufacturer or Trimethobenzamide HCl GMP API supplier for your needs.
A Trimethobenzamide HCl CoA (Certificate of Analysis) is a formal document that attests to Trimethobenzamide HCl's compliance with Trimethobenzamide HCl specifications and serves as a tool for batch-level quality control.
Trimethobenzamide HCl CoA mostly includes findings from lab analyses of a specific batch. For each Trimethobenzamide HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Trimethobenzamide HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Trimethobenzamide HCl EP), Trimethobenzamide HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trimethobenzamide HCl USP).
LOOKING FOR A SUPPLIER?